Bailey John E. (Jack) Jr. — SEC Form 4 filings

SEC reporting owner CIK 1806147. 4 Form 4 filings on record with FilingPulse; latest filed 2024-09-18.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-05-15 to 2024-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
G1 Therapeutics, Inc. (GTHX)President and CEO, Director42 legs · 44,920 sh · $197,6356

Form 4 filings — Bailey John E. (Jack) Jr.

FiledFormIssuerReported transactionsSource
2024-09-184G1 Therapeutics, Inc. (GTHX)Grant/award (A): 181,400 · Disposition to issuer (D): 534,787 · Code (U): 196,287 · Disposition to issuer (D): 201,300 (derivative) · Disposition to issuer (D): 161,300 (derivative)EDGAR
2024-07-084G1 Therapeutics, Inc. (GTHX)Sale (S): 7,662 @ $2.51EDGAR
2024-07-034G1 Therapeutics, Inc. (GTHX)Grant/award (A): 105,000 @ $0EDGAR
2024-05-154G1 Therapeutics, Inc. (GTHX)Sale (S): 37,258 @ $4.79EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1806147 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →